CCND2 and Alzheimer disease: In summary, our results provide evidence for the first time that the expression of cyclin D2 is reduced in in vitro experimental cellular models of the sporadic/genetic form of AD, in murine model of LPS-induced systemic inflammatory response (SIR), and in multiple post-mortem samples of sporadic AD brain compared to age- and gender-matched controls.